FIELD: medicine.
SUBSTANCE: sample is added with a panel of marked agents that binding to two or more markers expressed on a cell surface, wherein at least one of the agents is cancer-specific, and wherein the panel comprises: one or more agents bound to the cancer-specific markers, expressed on the colonic cancer cell surface, wherein one agent or one of the agents binding to CA 19-9, and one or more agents binding to tissue-specific markers that are epithelial and/or mesenchymal, expressed on the cell surface, wherein one agent or one of the agents is the agent binding to Ep-CAM. A kit comprising one or more agents binding to extracellular cancer-specific markers, wherein one agent or one of the agents is an antibody or antibody fragment binding to CA 19-9, and one or more agents binding to extracellular tissue-specific markers that are epithelial markers and/or mesenchymal markers, wherein one agent or one of the agents is the antibody or antibody fragment binding to the Ep-CAM.
EFFECT: using the declared method and kit allows the high-sensitivity and specificity detection of the colonic cancer cells.
5 cl, 5 tbl, 13 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
URGENT FLUORESCENT IMMUNOCYTOCHEMICAL DIAGNOSIS OF METASTATIC LYMPH NODE | 2014 |
|
RU2582275C1 |
METHOD FOR EMERGENCY FLUORESCENT DIFFERENTIAL IMMUNOCYTOCHEMICAL DIAGNOSIS OF CANCER METASTASES IN LYMPH NODES AND NON-HODGKIN LYMPHOMA | 2015 |
|
RU2580612C2 |
METHOD FOR DETECTING TUMOUR CELLS CIRCULATING IN BLOOD BY MULTIPARAMETER FLOW CYTOMETRY | 2024 |
|
RU2825188C2 |
REPRESENTATIVE DIAGNOSIS | 2016 |
|
RU2743169C2 |
SENTINEL LYMPH NODES DIAGNOSING METHOD IN GASTRIC CANCER | 2020 |
|
RU2727251C2 |
METHOD FOR DETERMINING CIRCULATING TUMOR CELLS IN PATIENTS WITH BREAST CANCER | 2021 |
|
RU2770284C1 |
AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
FLUORESCENT CONJUGATES AND USE THEREOF FOR TUMOR DIAGNOSTICS | 2016 |
|
RU2720976C2 |
MONOCLONAL ANTI-CLAUDIN-18 ANTIBODIES FOR TREATING CANCER | 2008 |
|
RU2571923C2 |
CANCER MARKER AND THERAPEUTIC TARGET | 2008 |
|
RU2529797C2 |
Authors
Dates
2013-08-10—Published
2008-02-27—Filed